Inflammatory myofibroblastic tumors;Tumeurs myofibroblastiques inflammatoires

Annales de Pathologie

Volumn 22, Issue 6, 2002, Pages 453-460

  Sirvent, Nicolas ^a   Coindre, Jean Michel ^a   Pedeutour, Florence ^a  

^a NONE

Author keywords

ALK; Chromosome 2; Cytogenetics; Inflammatory myofibroblastic tumor; Myofibroblast

Indexed keywords

PARAFFIN; PROTEIN TYROSINE KINASE; TYROSINE KINASE ALK; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; CHILD; CHROMOSOME 2P; CHROMOSOME ABERRATION; CYTOGENETICS; DIMERIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE EXPRESSION; GENE REARRANGEMENT; HEMATOPOIETIC CELL; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE; MESENCHYME; MESENCHYMOMA; MYOFIBROBLAST; ONCOGENE; PLASMA CELL; PROTEIN LOCALIZATION; SOLID TUMOR;

EID: 0036976038     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Weiss SW. Histological Typing of Soft Tissue Tumors. Berlin: Springer-Verlag, 1994.
2. Pettinato G, Manivel JC, DeRosa N, Dehner L. Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations. Am J Clin Pathol 1990; 94: 538-46.
3. Coffin CM, Dehner LP, Meis-Kindblom JM. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Sem Diagn Pathol 1998; 15: 102-10.
4. Majno G, Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR. Contraction of granulation tissue in vitro: similarity to smooth muscle. Science 1971; 173: 548-50.
5. Gabbiani G, Majno G. Dupuytren's contracture: fibroblast contraction? An ultrastructural study. Am J Pathol 1972; 66: 131-43.
6. Schurch W, Seemayer TA, Gabbiani G. Myofibroblast. In Sternberg SS, ed. Histology for pathologists. New York: Raven Press, 1992.
7. Hasegawa T, Hirose T, Kudo E, Abe J, Hizawa K. Cytoskeletal characteristics of myofibroblasts in benign, neoplastic and reactive fibroblastic lesions. Virchows Arch 1990; 416: 375-82.
8. Sappino AP, Schurch W, Gabbiani G. Differentiation repertoire of myofibroblast of fibroblastic cells. Expression of cytoskeletal proteins as markers for phenotypic modulations. Lab Invest 1990; 425: 3-24.
9. Gabbiani G. Modulation of fibroblastic cytoskeletal features during wound healing and fibrosis. Pathol Res Pract 1994; 190: 851-53.
10. Desmouliere A. Factors influencing myofibroblast differentiation during wound healing anf fibrosis. Cell Biol Int 1995; 19: 471-76.
11. Tomasek JJ, Haaksma CJ. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's disease tissue. Anat Rec 1991; 230: 175-82.
12. Fukasawa Y, Ishikura H, Takada A, Yokoyama S, Imamura M, Yoshiki T et al. Massive apoptosis in infantile myofibromatosis. A putative mechanism of tumor regression. Am J Pathol 1994; 144: 480-85.
13. Chan JC. Inflammatory pseudotumor: a family of lesions of diverse nature and etiologies. Adv anat pathol 1996; 3: 156-71.
14. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudo-tumor): a clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995; 19: 859-72.
15. Sastre-Garau X, Couturier J, Derré J, Aurias A, Klijanienko J, Lagacé R. Inflammatory myofibroblastic tumour (inflammatory pseudotumour) of the breast. Clinicopathological and genetic analysis of a case with evidence for clonality. J Pathol 2002; 196: 97-102.
16. Sirvent N, Hawkins A, Moeglin D, Coindre JM, Kurzenne JY, Michiels JF et al. ALK probe rearrangement in a t(2;11;2)(p23;p15;q31) translocation found in a prenatal myofibroblastic fibrous lesion. Toward a molecular definition of an inflammatory myofibroblastic tumor family. Genes Chromosomes Cancer 2001; 31: 85-90.
17. Coffin CM, Dehner LP. Fibroblastic-myofibroblastic tumors in children and adolescents: a clinicopathologic study of 108 examples in 103 patients. Pediatr Pathol 1991; 11: 559-88.
18. Meis JM, Enziger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol 1991; 15: 1146-1156.
19. Treissman SP, Gillis DA, Lee CL, Giacomantonio M, Reach L. Omental mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor. Cancer 1994; 73: 1433-37.
20. Snyder CS, Dell'Aquila M, Heghighi P, Beergan RN, Suth YK, Yi ES. Clonal changes in inflammatory pseudotumor of the lung: a case report. Cancer 1995; 76: 1545-49.
21. Griffin CA, Hawkins AL, Dvorak C, Henkle C, Ellingham T, Perlman EJ. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res 1999; 59: 2776-80.
22. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non Hodgkin's lymphoma. Science 1994; 263: 1281-84.
23. Weisenburger DD, Gordon BG, Vose JM, Bast MA, Chan WC, Greiner TC et al. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood 1996; 87: 3860-68.
24. Lawrence B, Perez-Atayde A, Hibbard MK, Rubin BP, Dal Cin P, Pinkus JL et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000; 157: 377-84.
25. Lamant L, Dastugue N, Pulford K, Delsol G, Mariame B. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood 1999; 93: 3088-95.
26. Pierotti MA, Vigneri P, Bongarzone I. Rearrangements of RET and NTRKI tyrosine kinase receptors in papillary thyroïd carcinomas. Recent Results Cancer Res 1998; 154: 237-47.
27. Bridge JA, Kanamori M, Ma Z, Pickering D, Hill DA, Lydiat W et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol 2001; 159: 411-15.
28. Cools J, Wlodarska I, Somers R, Mentens N, Pedeutour F, Maes B et al. Identification of novel fusion partners of ALK, the Anaplastic Lymphoma Kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2002; 34: 354-62.
29. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 fusion in congenital fibrosarcoma. Nature Genet 1998; 18: 184-87.
30. Eguchi M, Egushi-Ishimae M, Tojo A, Morishita K, Suzuki K, Sato Y et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloïd leukemia with t(12;15)(pl3;q25). Blood 1999; 93: 1356-63.
31. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 1993; 329: 958-9.
32. Petit MM, Schoenmakers EF, Huysmans C, Geurts JM, Mandahl N, Van de Ven WJ. LFHP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes. Genomics 1999; 57: 438-41.
33. Bischof D, Pulford K, Mason D, Morris SW. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol 1997; 17: 2312-25.
34. Maes B, Vanhentenrijk V, Wlodarska I, Cools J, Peeters B, Marynen P et al. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Am J Pathol 2001; 158: 2185-93.
35. Kuefer MU, Look AT, Pulford K, Behm FG, Pattengale PK, Mason DY et a[. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 1997; 90: 2901-10.
36. Prasad GL, Masuelli L, Raj MH, Harindranath N. Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene 1999; 18: 2027-31.
37. Falini B, Pileri S, Zinzani P, Carbone A, Zagonel V, Wolf-Peeters C et al. ALK + lymphoma: clinico-pathological findings and outcome. Blood 1999; 93: 2697-2706.
38. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1084-86.